{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:10279"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:10279","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Implementation and evaluation of physiotherapist independent prescribing: a mixed multi-methods analysis","abstract":"This research presents novel knowledge and insight into the effective implementation and utilisation of non-medical prescribing (NMP) across professions internationally. It will inform safe and effective implementation of physiotherapy independent prescribing across clinical specialities, settings and jurisdictions. Individual studies (systematic reviews, surveys, feasibility trial) were designed using rigorous mixed methods, addressing specific pre-determined aims and objectives generated from gaps in the literature. Rigorous evaluation established that the benefit of NMP to the health economy remains unclear and limited evidence exists evaluating its clinical effectiveness across professions and clinical settings. Internationally, physiotherapists support the introduction of physiotherapist prescribing. Physiotherapists surveyed in Australia perceived potential benefits across the population, within a multimodal-physiotherapeutic context. Barriers and facilitators of the implementation/utilisation of NMP demonstrate multifactorial context specific variables. The resulting implementation framework may be useful to aid safe and successful implementation/utilisation of NMP. Low risk of bias trials are required to evaluate the clinical and cost-effectiveness of physiotherapist prescribing across a range of clinical specialities and settings. High-quality feasibility trial data demonstrates that with minor modifications, a low risk of bias trial to evaluate clinical and cost-effectiveness of physiotherapist independent prescribing for low back pain in primary care is feasible, suitable and acceptable.","abstract_html":"This research presents novel knowledge and insight into the effective implementation and utilisation of non-medical prescribing (NMP) across professions internationally. It will inform safe and effective implementation of physiotherapy independent prescribing across clinical specialities, settings and jurisdictions. Individual studies (systematic reviews, surveys, feasibility trial) were designed using rigorous mixed methods, addressing specific pre-determined aims and objectives generated from gaps in the literature. Rigorous evaluation established that the benefit of NMP to the health economy remains unclear and limited evidence exists evaluating its clinical effectiveness across professions and clinical settings. Internationally, physiotherapists support the introduction of physiotherapist prescribing. Physiotherapists surveyed in Australia perceived potential benefits across the population, within a multimodal-physiotherapeutic context. Barriers and facilitators of the implementation/utilisation of NMP demonstrate multifactorial context specific variables. The resulting implementation framework may be useful to aid safe and successful implementation/utilisation of NMP. Low risk of bias trials are required to evaluate the clinical and cost-effectiveness of physiotherapist prescribing across a range of clinical specialities and settings. High-quality feasibility trial data demonstrates that with minor modifications, a low risk of bias trial to evaluate clinical and cost-effectiveness of physiotherapist independent prescribing for low back pain in primary care is feasible, suitable and acceptable.","abstract_has_math":false,"creators":["Noblet, Timothy David"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2020,"date_issued":"2020-07","date_published":"2020-07","updated_at":"2026-11-19T09:31:05Z","subjects":["RM Therapeutics. Pharmacology","RZ Other systems of medicine"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/10279/7/Noblet2020PhD_Redacted.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A10279","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["na"]},{"key":"dc:creator","label":"Author","values":["Noblet, Timothy David"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2020-07-20"]},{"key":"dc:date.issued","label":"Date","values":["2020-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Life & Environmental Sciences","School of Sport, Exercise and Rehabilitation Sciences"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/10279/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["RM Therapeutics. Pharmacology","RZ Other systems of medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/10279/7/Noblet2020PhD_Redacted.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["This research presents novel knowledge and insight into the effective implementation and utilisation of non-medical prescribing (NMP) across professions internationally. It will inform safe and effective implementation of physiotherapy independent prescribing across clinical specialities, settings and jurisdictions. Individual studies (systematic reviews, surveys, feasibility trial) were designed using rigorous mixed methods, addressing specific pre-determined aims and objectives generated from gaps in the literature. Rigorous evaluation established that the benefit of NMP to the health economy remains unclear and limited evidence exists evaluating its clinical effectiveness across professions and clinical settings. Internationally, physiotherapists support the introduction of physiotherapist prescribing. Physiotherapists surveyed in Australia perceived potential benefits across the population, within a multimodal-physiotherapeutic context. Barriers and facilitators of the implementation/utilisation of NMP demonstrate multifactorial context specific variables. The resulting implementation framework may be useful to aid safe and successful implementation/utilisation of NMP. Low risk of bias trials are required to evaluate the clinical and cost-effectiveness of physiotherapist prescribing across a range of clinical specialities and settings. High-quality feasibility trial data demonstrates that with minor modifications, a low risk of bias trial to evaluate clinical and cost-effectiveness of physiotherapist independent prescribing for low back pain in primary care is feasible, suitable and acceptable."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Implementation and evaluation of physiotherapist independent prescribing: a mixed multi-methods analysis"]}]}],"canonical_facts":{"dc:contributor.sponsor":["na"],"dc:creator":["Noblet, Timothy David"],"dc:date":["2020-07-20"],"dc:date.issued":["2020-07"],"dc:description.abstract":["This research presents novel knowledge and insight into the effective implementation and utilisation of non-medical prescribing (NMP) across professions internationally. It will inform safe and effective implementation of physiotherapy independent prescribing across clinical specialities, settings and jurisdictions. Individual studies (systematic reviews, surveys, feasibility trial) were designed using rigorous mixed methods, addressing specific pre-determined aims and objectives generated from gaps in the literature. Rigorous evaluation established that the benefit of NMP to the health economy remains unclear and limited evidence exists evaluating its clinical effectiveness across professions and clinical settings. Internationally, physiotherapists support the introduction of physiotherapist prescribing. Physiotherapists surveyed in Australia perceived potential benefits across the population, within a multimodal-physiotherapeutic context. Barriers and facilitators of the implementation/utilisation of NMP demonstrate multifactorial context specific variables. The resulting implementation framework may be useful to aid safe and successful implementation/utilisation of NMP. Low risk of bias trials are required to evaluate the clinical and cost-effectiveness of physiotherapist prescribing across a range of clinical specialities and settings. High-quality feasibility trial data demonstrates that with minor modifications, a low risk of bias trial to evaluate clinical and cost-effectiveness of physiotherapist independent prescribing for low back pain in primary care is feasible, suitable and acceptable."],"dc:format":["text"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/10279/7/Noblet2020PhD_Redacted.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Life & Environmental Sciences","School of Sport, Exercise and Rehabilitation Sciences"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/10279/"],"dc:subject":["RM Therapeutics. Pharmacology","RZ Other systems of medicine"],"dcterms:accessrights":["public"],"dc:title":["Implementation and evaluation of physiotherapist independent prescribing: a mixed multi-methods analysis"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"]},"updated_at":"2026-11-19T09:31:05Z"}